Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

November 30, 2005

Conditions

Perennial Allergic RhinoconjunctivitisAllergic Asthma

Interventions

BIOLOGICAL

CYT005-AllQbG10

Immunomodulator CYT003-QbG10 in combination with commercial house dust mite extract as used for routine SIT

Trial Locations (1)

University Hospital Zurich, Department of Dermatology, Zurich